Results 1 to 10 of about 3,333,027 (254)

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. [PDF]

open access: yesJ Am Heart Assoc, 2018
Background Our objective was to determine patterns of antihypertensive agent use by stage of chronic kidney disease (CKD) and to evaluate the association between different classes of antihypertensive agents with nonrenal outcomes, especially in advanced ...
Ku E   +4 more
europepmc   +4 more sources

Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19. [PDF]

open access: yesCardiovasc Drugs Ther, 2022
The role of angiotensin receptor blockers (ARB), angiotensin-converting enzyme inhibitors (ACEi), or other antihypertensive agents in the case of Covid-19 remains controversial.
Chouchana L   +12 more
europepmc   +2 more sources

Antihypertensive Agents and Incident Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Observational Studies [PDF]

open access: yesThe journal of prevention of Alzheimer's disease, 2022
Background Hypertension is a recognized risk factor for dementia. However, evidence for using antihypertensive agents to reduce the risk of Alzheimer’s disease in people with hypertension is inconclusive. Objective To examine the association between
Adesuyan, M   +7 more
core   +2 more sources

Systolic Blood Pressure Variability When Transitioning From Intravenous to Enteral Antihypertensive Agents in Patients With Hemorrhagic Strokes [PDF]

open access: yesFrontiers in Neurology, 2022
Background/ObjectiveSystolic blood pressure variability (SBPV) in patients with intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH) is associated with an increased risk of acute kidney injury (AKI) and mortality. SBPV is a strong predictor of
Abdulrahman I. Alshaya   +18 more
doaj   +2 more sources

Antihypertensive agents: a long way to safe drug prescribing in children. [PDF]

open access: yesPediatr Nephrol, 2020
Recently updated clinical guidelines have highlighted the gaps in our understanding and management of pediatric hypertension. With increased recognition and diagnosis of pediatric hypertension, the use of antihypertensive agents is also likely to ...
Siddiqi N, Shatat IF.
europepmc   +2 more sources

Antihypertensive agents and arterial stiffness. [PDF]

open access: yesJ Thorac Dis, 2016
Carotid-femoral pulse wave velocity (cfPWV) is the goldstandard method to measure arterial stiffness (1), which has been shown to be an important predictor of cardiovascular events and death (1-3).
Gismondi RA, Oigman W, Neves MF.
europepmc   +5 more sources

Risk of Parkinson's Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational Studies. [PDF]

open access: yesJ Neurodegener Dis, 2016
Background. Antihypertensive agents have been shown to inhibit oxidative stress and inflammatory response and thus neuroprotection in Parkinson's disease (PD).
Mullapudi A   +3 more
europepmc   +2 more sources

Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis. [PDF]

open access: yesBr J Clin Pharmacol, 2014
AIMS In response to safety concerns from two large randomized controlled trials, we investigated whether the use of telmisartan, an angiotensin receptor blocker (ARB), ARBs as a class and angiotensin-converting enzyme inhibitors (ACEIs) increase the risk
Dial S   +4 more
europepmc   +2 more sources

Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study. [PDF]

open access: yesPLoS One, 2014
Background and Purpose Hypertension has been associated with Parkinson's disease (PD), but data on antihypertensive drugs and PD are inconclusive. We aim to evaluate antihypertensive drugs for an association with PD in hypertensive patients.
Lee YC   +5 more
europepmc   +2 more sources

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [PDF]

open access: yesPatient Preference and Adherence, 2019
Hamzah Bakouni,1,2 Lia Gentil,3 Helen-Maria Vasiliadis1–2,41Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada; 2Centre de recherche Charles-Le Moyne – Saguenay–Lac-Saint-Jean sur les ...
Bakouni H, Gentil L, Vasiliadis HM
doaj   +2 more sources

Home - About - Disclaimer - Privacy